Menu
Back to Journals » Cancer Management and Research » Volume 12
Original Research
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,645 | Dovepress* | 7,369+ | 1,156 | 8,525 | |
| PubMed Central* | 1,276 | 285 | 1,561 | ||
| Totals | 8,645 | 1,441 | 10,086 | ||
| *Since 3 June 2020 | |||||
View citations on PubMed Central and Google Scholar